Axithra Alternatives & Competitors
12 companies similar to Axithra — Rapid Therapeutic Drug Monitoring
Deep Breath 🫁
Better ICU care is here. Just ask the data.
Resuscitec
Life is our mission
ARTCLINE GmbH
Innovative therapeutic procedures for Intensive Care Medicine for the treatment of severe...
Clinomic
Reinventing the hospital.
Track all Axithra competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Labenko
Integrating and Automating Preanalytics by AI, Robotics
Solvemed | PuRe Pupillometer
Decoding neurology. In the blink of AI.
Hedera Dx
Modern cancer care to the next billion people
QuantumCyte, Inc.
Sample in. Clarity out.
Vitara Biomedical
Because every day counts
Ceribell │ AI-Powered Point-of-Care EEG
AI-powered point-of-care EEG revolutionizing seizure management in acute care
GCX
Worldwide leader in medical instrument and IT mounting solutions
IQ Products
A medical diagnostic company providing niche specific antibody based solutions
About Axithra
Rapid Therapeutic Drug Monitoring
Rapid therapeutic drug monitoring, Active drug fraction measurement, Multi-drug quantification
Healthcare professionals, Intensive care units, Clinical laboratories, Hospital pharmacists
Therapeutic Drug Monitoring, Personalized Medicine, Beta-lactam Antibiotics, Intensive Care Unit, Drug Concentration Measurement, Optical Technology, Photonics Technology, Platform Development, Healthcare Innovation, Patient Care Optimization, Proprietary Technology, Spin-off Startup
B2B, B2D, SaaS
Usage Based, Service Fee, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Axithra and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Axithra on 11 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 7 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.